Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00032630 · ClinicalTrials.gov registry record · Phase 3

Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass

A Phase 3 study, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 3
Development phase
2,203
Enrollment target

NCT00032630 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 2,203 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00032630, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 3
Development phase
2,203 participants
Enrollment target

Study Summary

Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in Fiscal Year (FY) 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now being performed using two surgical techniques. One technique is performed with cardiopulmonary bypass (CPB) usually with cardioplegic arrest ("on-pump") and the other without CPB on a beating heart ("off-pump"). The overall purpose of this proposed randomized, controlled, clinical trial is to rigorously evaluate the impact of using an on-pump versus off-pump surgical technique for coronary artery bypass graft (CABG-only) procedures (performed with a traditional median sternotomy incision) upon patient clinical outcomes and resource utilization.

Interventions

  • PROCEDURE Coronary artery bypass - on-pump
  • PROCEDURE Coronary artery bypass - off-pump

Trial Details

FieldValue
Enrollment Target 2,203 participants
Start Date 2002-04
Est. Completion 2008-04
Phase Phase 3

Sponsor

US Department of Veterans Affairs

632 total trials

What the Registry Record Tells You About NCT00032630

The ClinicalTrials.gov registry entry for NCT00032630 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Coronary artery bypass - on-pump is the first listed.

NCT00032630 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00032630 about?

NCT00032630 is a clinical study titled "Outcomes Following Myocardial Revascularization: On and Off Cardiopulmonary Bypass". Ischemic heart disease is one of the most frequent diagnoses in the VA system. Moreover, 5,819 coronary artery bypass graft (CABG-only) procedures were performed in the VA in Fiscal Year (FY) 1999. Throughout VA and non-VA cardiac surgery programs nationwide, myocardial revascularization is now bein...

What is the current status of trial NCT00032630?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,203 participants. The study started on 2002-04. Estimated completion is 2008-04.

What interventions are being tested in trial NCT00032630?

The interventions under investigation include: Coronary artery bypass - on-pump (PROCEDURE), Coronary artery bypass - off-pump (PROCEDURE).

Who is sponsoring clinical trial NCT00032630?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.